A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833

Trial Identifier:	D8532C00005
Sponsor:	AstraZeneca
Collaborator:	Quotient Sciences Ltd
NCTID::	NCT05364255
Start Date:	May 2022
Primary Completion Date:	June 2022
Study Completion Date:	June 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	English (UK) Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Ruddington, GB, NG11 6JS

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.